INJECTABLE PEPTIDES Injectables offer the highest bioavailability
KLOW is a quad-peptide blend containing BPC-157 (a 15-amino acid gastric peptide), TB-500 (a 43-amino acid thymosin beta-4 fragment), GHK-Cu (a copper tripeptide), and KPV (a 3-amino acid -MSH fragment)
BPC-157 upregulates vascular endothelial growth factor (VEGF) expression, promoting new blood vessel formation and enhancing blood supply to injured tissue in preclinical models
Using bulk RNA-sequencing data, we found that lower expression of mevalonate decarboxylase ( MVD ), mevalonate kinase ( MVK ), farnesyl diphosphate synthase ( FDPS ), and farnesyl diphosphate farnesyltransferase 1 ( FDFT1 ) was independently associated with improved survival (Figure 1CD)
H tr iu tr chy mu di nhn, ci thin triu chng